SpaceX’s IPO Hangover Meets the AI Disclosure Bill
Friday, June 26, 2026 · 9 min
SpaceX IPO aftershocks are the center of gravity: shares are off sharply, Damodaran is revisiting the prospectus, and AI-token cost disclosure is becoming an S-1 and MD&A issue for OpenAI- and Anthropic-style economics.
Listen
Show notes
SpaceX IPO aftershocks are the center of gravity: shares are off sharply, Damodaran is revisiting the prospectus, and AI-token cost disclosure is becoming an S-1 and MD&A issue for OpenAI- and Anthropic-style economics.
In this episode
- SpaceX has been retreating post IPO. What is the outlook for the stock now? And how might a repricing affect the market? – Oninvest — Oninvest
SpaceX has been retreating post IPO. What is the outlook for the stock now? And how might a repricing affect the market? – Oninvest · Review 23.06.2026 16:06 Share # 'Priced on narrative': How SpaceX could jeopardize other mega IPOs and the AI story Shares of Elon Musk's SpaceX have slid over 20% in the last three days. Oninvest talked to analysts who see a fundamentals-driven repricing…
- Musings on Markets: Revisiting the SpaceX Valuation: A Post-Prospectus Update! — Musings on Markets
Musings on Markets: Revisiting the SpaceX Valuation: A Post-Prospectus Update! A few weeks ago, I assessed the value of SpaceX ahead of its initial public offering, with the admission that I was making my estimates with drabs of data, some of it coming from unofficial sources. I also promised to revisit my valuation, when the prospectus came out, and now that it has, I will examine how the…
“SpaceX is Tesla on steroids --- bigger and bolder. If you think Tesla with a P/E of 385 is on the verge of taking over personal transportation, SpaceX is probably right for you. Maybe Musk should try his hand at religion. He already has a substantial following.” — Hacker News (4 pts thread)
Our take: We understand the Tesla-on-steroids shorthand because a lot of the premium is still Musk-and-mission narrative. The religion line is funny, but valuation work still has to separate cult multiple from cash flows, debt capacity, and disclosed operating data.
- Step Back — When a private AI company is inching toward an IPO, what are executives actually allowed to say publicly—and how can loose comments about valuation or timing create SEC problems or mislead investors?
Background sources
- S-1 Step at a Time: Understanding Communications During the Pre-Filing Period of a Securities IPO - Barakat + Bossa — B2B
- When IPOs go wrong: SpaceX, AI firms face a delicate process | WTAQ News Talk | 97.5 FM · 1360 AM | Green Bay, WI — Green Bay, WI
- When IPOs go wrong: SpaceX, AI firms face a delicate process - The Economic Times — ET
- Governing AI Through SEC Disclosure — Amazonaws
- What Anthropic Can't Say in Its S-1 — Sloppish — Sloppish
- What Founders Must Know On Testing-the-Waters Meetings Pre-IPO - Listing Rules & Flotation - United States — Craig Garvey
- AI Token Costs and MD&A Disclosure — JDSupra
# AI Token Costs and MD&A Disclosure Published: 2026-06-23T23:00:56+00:00 Source: jdsupra.com (jdsupra.com) Language: en ## Story The fast-changing economics of artificial intelligence (AI) use by public companies will require public companies’ disclosure obligations to change with them. AI model providers, including Anthropic, OpenAI, Microsoft, and Salesforce, are moving away from flat-fee,…